{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T07:24:11Z","timestamp":1778311451137,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2009.01.097","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T09:28:27Z","timestamp":1233480507000},"page":"2171-2176","source":"Crossref","is-referenced-by-count":16,"title":["Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: Results of a Phase I randomized trial"],"prefix":"10.1016","volume":"27","author":[{"given":"Kirsten E.","family":"Lyke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Modibo","family":"Daou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issa","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdoulaye","family":"Kone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bourema","family":"Kouriba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamadou A.","family":"Thera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheetij","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Lanar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"D. Gray","family":"Heppner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ogobara K.","family":"Doumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher V.","family":"Plowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo B.","family":"Sztein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April 27 (23)","key":"10.1016\/j.vaccine.2009.01.097_bib1","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.vaccine.2004.09.040","article-title":"A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant","volume":"23","author":"Saul","year":"2005","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.01.097_bib2","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria","volume":"73","author":"Malkin","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.097_bib3","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2007.03.012","article-title":"Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naive adults at the Walter Reed Army Institute of Research","volume":"March 26 (25)","author":"Polhemus","year":"2007","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.01.097_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/IAI.72.1.154-158.2004","article-title":"Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells","volume":"72","author":"Mitchell","year":"2004","journal-title":"Infect Immun"},{"issue":"October 15 (29)","key":"10.1016\/j.vaccine.2009.01.097_bib5","doi-asserted-by":"crossref","first-page":"17974","DOI":"10.1016\/S0021-9258(18)38259-0","article-title":"A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium","volume":"265","author":"Waters","year":"1990","journal-title":"J Biol Chem"},{"issue":"April 12 (15)","key":"10.1016\/j.vaccine.2009.01.097_bib6","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1073\/pnas.0501594102","article-title":"Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx","volume":"102","author":"Kato","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"November 15 (46)","key":"10.1016\/j.vaccine.2009.01.097_bib7","doi-asserted-by":"crossref","first-page":"29446","DOI":"10.1074\/jbc.271.46.29446","article-title":"The disulfide bond structure of Plasmodium apical membrane antigen-1","volume":"271","author":"Hodder","year":"1996","journal-title":"J Biol Chem"},{"issue":"January (2\u20133)","key":"10.1016\/j.vaccine.2009.01.097_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0264-410X(97)88331-4","article-title":"Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi","volume":"16","author":"Anders","year":"1998","journal-title":"Vaccine"},{"issue":"December 1 (11)","key":"10.1016\/j.vaccine.2009.01.097_bib9","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.4049\/jimmunol.159.11.5535","article-title":"A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design","volume":"159","author":"Amante","year":"1997","journal-title":"J Immunol"},{"issue":"October 14 (21)","key":"10.1016\/j.vaccine.2009.01.097_bib10","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.1073\/pnas.2032858100","article-title":"Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites","volume":"100","author":"Dutta","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.01.097_bib11","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1128\/IAI.69.5.3286-3294.2001","article-title":"Specificity of the protective antibody response to apical membrane antigen 1","volume":"69","author":"Hodder","year":"2001","journal-title":"Infect Immun"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.01.097_bib12","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/IAI.70.8.4471-4476.2002","article-title":"High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion","volume":"70","author":"Kocken","year":"2002","journal-title":"Infect Immun"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.01.097_bib13","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1128\/IAI.70.12.6961-6967.2002","article-title":"Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria","volume":"70","author":"Stowers","year":"2002","journal-title":"Infect Immun"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.01.097_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4269\/ajtmh.1994.51.711","article-title":"Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile","volume":"51","author":"Collins","year":"1994","journal-title":"Am J Trop Med Hyg"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.01.097_bib15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-3024.1988.tb00241.x","article-title":"Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66kDa merozoite antigen","volume":"10","author":"Deans","year":"1988","journal-title":"Parasite Immunol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.01.097_bib16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4269\/ajtmh.1994.51.730","article-title":"High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83\/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83\/AMA-1","volume":"51","author":"Thomas","year":"1994","journal-title":"Am J Trop Med Hyg"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2009.01.097_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4269\/ajtmh.2001.65.100","article-title":"Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII","volume":"65","author":"Udhayakumar","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"December 16 (5)","key":"10.1016\/j.vaccine.2009.01.097_bib18","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.vaccine.2004.05.031","article-title":"Human antibodies to recombinant protein constructs of Plasmodium falciparum apical membrane antigen 1 (AMA1) and their associations with protection from malaria","volume":"23","author":"Polley","year":"2004","journal-title":"Vaccine"},{"issue":"June 27 (26)","key":"10.1016\/j.vaccine.2009.01.097_bib19","doi-asserted-by":"crossref","first-page":"23890","DOI":"10.1074\/jbc.M302160200","article-title":"A single malaria merozoite serine protease mediates shedding of multiple surface proteins by juxtamembrane cleavage","volume":"278","author":"Howell","year":"2003","journal-title":"J Biol Chem"},{"issue":"March 5 (10)","key":"10.1016\/j.vaccine.2009.01.097_bib20","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1074\/jbc.M311331200","article-title":"A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites","volume":"279","author":"Silvie","year":"2004","journal-title":"J Biol Chem"},{"issue":"October 3 (6906)","key":"10.1016\/j.vaccine.2009.01.097_bib21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01107","article-title":"A proteomic view of the Plasmodium falciparum life cycle","volume":"419","author":"Florens","year":"2002","journal-title":"Nature"},{"issue":"July 1 (1)","key":"10.1016\/j.vaccine.2009.01.097_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4049\/jimmunol.165.1.389","article-title":"CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization","volume":"165","author":"Xu","year":"2000","journal-title":"J Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.01.097_bib23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/IAI.64.3.1054-1059.1996","article-title":"Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria","volume":"64","author":"Lal","year":"1996","journal-title":"Infect Immun"},{"issue":"October 15 (8)","key":"10.1016\/j.vaccine.2009.01.097_bib24","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.4049\/jimmunol.155.8.4072","article-title":"T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens","volume":"155","author":"Krzych","year":"1995","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.097_bib25","doi-asserted-by":"crossref","first-page":"e1465","DOI":"10.1371\/journal.pone.0001465","article-title":"Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial","volume":"3","author":"Thera","year":"2008","journal-title":"PLoS ONE"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.01.097_bib26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4269\/ajtmh.2002.67.604","article-title":"Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali","volume":"67","author":"Coulibaly","year":"2002","journal-title":"Am J Trop Med Hyg"},{"issue":"August 13 (23\u201324)","key":"10.1016\/j.vaccine.2009.01.097_bib27","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2004.01.054","article-title":"Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali","volume":"22","author":"Lyke","year":"2004","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.01.097_bib28","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/IAI.70.6.3101-3110.2002","article-title":"Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli","volume":"70","author":"Dutta","year":"2002","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.01.097_bib29","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.68.3.1196-1201.2000","article-title":"Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers","volume":"68","author":"Tacket","year":"2000","journal-title":"Infect Immun"},{"issue":"August 15 (4)","key":"10.1016\/j.vaccine.2009.01.097_bib30","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.4049\/jimmunol.169.4.2196","article-title":"Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain Ty21a typhoid vaccine","volume":"169","author":"Salerno-Goncalves","year":"2002","journal-title":"J Immunol"},{"issue":"November 15 (10)","key":"10.1016\/j.vaccine.2009.01.097_bib31","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.4049\/jimmunol.161.10.5284","article-title":"Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis","volume":"161","author":"Waldrop","year":"1998","journal-title":"J Immunol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.01.097_bib32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2133.2002.04850.x","article-title":"Cytokine production in nickel-sensitized individuals analysed with enzyme-linked immunospot assay: possible implication for diagnosis","volume":"147","author":"Jakobson","year":"2002","journal-title":"Br J Dermatol"},{"issue":"September 28 (29\u201330)","key":"10.1016\/j.vaccine.2009.01.097_bib33","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.vaccine.2004.07.023","article-title":"Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum","volume":"22","author":"Pichyangkul","year":"2004","journal-title":"Vaccine"},{"issue":"October 30 (42\u201343)","key":"10.1016\/j.vaccine.2009.01.097_bib34","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1016\/j.vaccine.2006.06.033","article-title":"Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS S\/AS02A","volume":"24","author":"Stewart","year":"2006","journal-title":"Vaccine"},{"issue":"January 15 (2)","key":"10.1016\/j.vaccine.2009.01.097_bib35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1073\/pnas.0709969105","article-title":"Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria","volume":"105","author":"Torcia","year":"2008","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T20:56:24Z","timestamp":1684875384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09001601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":35,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09001601"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.097","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}